Total Funding
57
80
Total FundingPost-IPO Equity raised
Growth Score
-19 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
5770
GeneDx uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.
Thomas Neyarapally: Chief Commercial Officer & Founding Team MemberPast Role: Big Brothers Big Sisters, Big Brother
Jason Ryan: DirectorPast Role: Taligen Therapeutics, Sr. Director, Finance and Business Operations
About the Company
GeneDx is focused on delivering personalized, actionable insights that improve health outcomes. GeneDx sit at the intersection of diagnostics and data science, pairing decades of genomic expertise with an unmatched ability to interpret clinical data at scale.
